Acyl-CoA:Cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-leiden mice

Circulation

Volumn 103, Issue 13, 2001, Pages 1778-1786

  Delsing, Dianne J M ^a,b   Offerman, Erik H ^a,b   Van Duyvenvoorde, Wim ^a,b   Van Der Boom, Hans ^a,b   De Wit, Elly C M ^a,b   Gijbels, Marion J J ^a,b   Van Der Laarse, Arnoud ^a,b   Jukema, J Wouter ^a,b   Havekes, Louis M ^a,b   Princen, Hans M G ^a,b  

^a TNO   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Atherosclerosis; Cell adhesion molecules; Inhibitors; Lipoproteins

Indexed keywords

AVASIMIBE; CELL ADHESION MOLECULE; CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE INHIBITOR; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; AORTA ROOT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; FEMALE; LEUKOCYTE ADHERENCE; LIPOPROTEIN BLOOD LEVEL; MONOCYTE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL;

EID: 0035799373     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.13.1778     Document Type: Article

References (35)

1. Role of acyl-CoA: Cholesterol acyltransferase in cellular cholesterol metabolism
2. The pathogenesis of atherosclerosis: A perspective for the 1990s
3. Emerging therapies in atherosclerosis
4. Therapeutic potential of ACAT inhibitors as lipid lowering and anti-atherosclerotic agents
5. Macrophages and atherosclerotic plaque stability
6. ACAT inhibitors: Physiologic mechanisms for hypolipidemic and anti-atherosclerotic activities in experimental animals
7. CL 277,082: A novel inhibitor of ACAT-catalyzed cholesterol esterification and cholesterol absorption
8. Inhibition of cholesterol esterification by DuP 128 decreases hepatic apolipoprotein B secretion in vivo: Effect of dietary fat and cholesterol
9. The ACAT inhibitor, CI-1011 is effective in the prevention and regression of aortic fatty streak area in hamsters
10. Heterocyclic amides: Inhibitors of acyl-CoA:cholesterol O-acyl transferase with hypocholesterolemic activity in several species and antiatherosclerotic activity in the rabbit
11. RP-70676: A potent systemically available inhibitor of acyl-CoA:cholesterol o-acyl transferase (ACAT)
12. CL 277,082, a novel inhibitor of cholesterol esterification and cholesterol absorption
13. Anti-atherosclerotic effect of E5324, an inhibitor of acyl-CoA: Cholesterol acyltransferase, in Watanabe heritable hyperlipidemic rabbits
14. Comparison of CI-976, an ACAT inhibitor, and selected lipid-lowering agents for antiatherosclerotic activity in iliac- femoral and thoracic aortic lesions: A biochemical, morphological, and morphometric evaluation
15. Animal models of atherosclerosis and interpretation of drug intervention studies
16. Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia
17. Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice
18. Quantitative assessment of aortic atherosclerosis in APOE*3 Leiden transgenic mice and its relationship to serum cholesterol exposure
19. Atherosclerosis in APOE*3-Leiden transgenic mice: From proliferative to atheromatous stage
20. Effects of dietary fish oil on serum lipids and VLDL kinetics in hyperlipidemic apolipoprotein E*3-Leiden transgenic mice
21. Apolipoprotein E*3-Leiden transgenic mice as a test model for hypolipidaemic drugs
22. Acyl-coenzyme A:cholesterol acyltransferase inhibitor, avasimibe, stimulates bile acid synthesis and cholesterol 7α-hydroxylase in cultured rat hepatocytes and in vivo in the rat
23. Cellular free cholesterol in Hep G2 cells is only partially available for down-regulation of low-density-lipoprotein receptor activity
24. Progression and regression of atherosclerosis in APOE3-Leiden transgenic mice: An immunohistochemical study
25. The ACAT inhibitor avasimibe reduces macrophages and matrix metalloproteinase expression in atherosclerotic lesions of hypercholesterolemic rabbits
26. Effects of intracellular free cholesterol accumulation on macrophage viability: A model for foam cell death
27. Inhibitors of acyl-CoA: Cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents: CI-1011: An acyl sulfamate with unique cholesterol-lowering activity in animals fed noncholesterol-supplemented diets
28. ACAT inhibitors decrease secretion of cholesteryl esters and apolipoprotein B by perfused livers of African green monkeys
29. Inhibition of hepatic ACAT decreases apoB secretion in miniature pigs fed a cholesterol-free diet
30. Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B production in miniature pigs
31. Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice
32. Synthetic low and high fat diets for the study of atherosclerosis in the mouse
33. Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semipurified diets with and without cholate
34. Coronary plaque disruption
35. Acyl-coenzyme A:cholesterol-acyltransferase (ACAT) inhibitors modulate monocyte adhesion to aortic endothelial cells